27.5 C
Vientiane
Monday, September 29, 2025
spot_img
Home Blog Page 38

LG Innotek Acquires Large-scale Funding from IFC “Proof of World-leading ESG Management”

  • Successful funding of USD 200 million, to be utilized for expansion of production facility in Vietnam
  • Spotlighting of outstanding ESG management metrics’ recognition by global institution with stringent standards 

SEOUL, South Korea, Sept. 24, 2025 /PRNewswire/ — LG Innotek (CEO Moon Hyuksoo) announced on 24th September the successful acquisition of large-scale funding from the International Finance Corporation (IFC) in recognition of its outstanding performance in ESG (environmental, social, and governance) management.

The IFC, a member of the World Bank Group, is an international financial institution that supports private sector investment.

LG Innotek applied for the IFC’s Sustainability-Linked Loan (SLL) last year to invest in the expansion of its production facility in Hai Phong, Vietnam, becoming the first Korean company to secure a total of USD 200 million. The loan has a maturity of eight years.

Introduced in 2017, the SLL is an international financial mechanism designed to promote ESG management among global companies. Companies with higher ESG performance and compliance metrics benefit from greater interest rate reductions.

Most importantly, unlike the Green Loan, which requires the funds to be applied only to ESG-specific projects, the SLL can be used for various purposes. This is the reason for the rigorous approval process and strictly regulated loan execution management and supervision. Throughout the term of the loan, the company must meet ESG management targets agreed upon in advance with the bank to continue to benefit from the low interest rate.

An LG Innotek official said, “LG Innotek’s satisfying the rigorous standards of a reputable international organization to successfully secure SLL funding once again demonstrates its unrivaled ESG management capacity worldwide.”

In 2022, the company set the ambitious goals of converting 100% of its electricity use to renewable energy (RE100, Renewable Electricity 100) by 2030 and achieving carbon neutrality by 2040.

It has since established a comprehensive roadmap to achieve the first goal, and as of 2024, 60% of its electricity use is renewable. This is the highest conversion rate among Korean companies that have joined RE100, with the exception of the Korea Water Resources Corporation, which engages in a renewable energy business. Notably, its plants in Paju and Gumi in South Korea, along with its facilities in Vietnam, achieved RE100 status last year.

These efforts earned LG Innotek a “Leadership A” rating in the 2024 Carbon Disclosure Project’s Climate Change Response Assessment and led to it being named the Leading Carbon Management Company for the third consecutive year.

Carsten Müeller, the IFC’s Regional Industry Director for Manufacturing, Agribusiness, and Services in Asia and the Pacific, stated, “We are delighted to sign the first SLL with LG Innotek. We look forward to continuing our work with LG Innotek to promote sustainability.”

LG Innotek CFO Jihwan Park(Executive Vice President) commented, “This IFC funding is a meaningful financial outcome of the company’s authentic ESG management activities. Going forward, we will continue to lead in ESG management while delivering exceptional value to our customers.”

Jihwan Park, CFO (Executive Vice President, right) of LG Innotek, and Carsten Müeller, the IFC’s Regional Industry Director for Manufacturing, Agribusiness, and Services in Asia and the Pacific at IFC, pose for a commemorative photo after concludinsg the Sustainability-Linked Loan (SLL) signing ceremony held recently in Seoul.
Jihwan Park, CFO (Executive Vice President, right) of LG Innotek, and Carsten Müeller, the IFC’s Regional Industry Director for Manufacturing, Agribusiness, and Services in Asia and the Pacific at IFC, pose for a commemorative photo after concludinsg the Sustainability-Linked Loan (SLL) signing ceremony held recently in Seoul.

 

Empowering ASEAN Development Across the Value Chain, Genertec Shines at the 22nd China-ASEAN Expo


NANNING, CHINA – Media OutReach Newswire – 24 September 2025 – On September 17, the 22nd China-ASEAN Expo (CAEXPO) opened grandly in Nanning, Guangxi.

1 (7).jpg

With the theme “Promoting AI Empowerment and Innovation for A New Shared Future”, this year’s CAEXPO covers 160,000 square meters and brings together more than 3,200 exhibitors. At the central SOE pavilion, Genertec showcased under the theme “Integration and Smart Manufacturing for a Sustainable Future”, highlighting its latest achievements in deepening its strategic layout of the ASEAN market and driving high-quality development through cutting-edge technological, business model, and service innovation. During the event, Genertec also co-hosted a promotion and exchange session under the theme “Joining Hands with ASEAN to Forge Cooperation, Igniting Intelligence to Unveil a New Future”, underscoring its role as both a “value chain integrator” and a “regional development enabler” in building a closer China-ASEAN community with a shared future.

Three specialized zones: Showcasing full-chain cooperation strength

At its 360-square-meter booth, Genertec highlighted three key sectors—international engineering, advanced equipment, and innovation services—directly responding to ASEAN’s twin demands for better infrastructure and upgraded manufacturing.

International engineering powering regional growth: By combining physical models with immersive VR, Genertec presented its landmark projects along the Belt and Road, showcasing full-chain capabilities in infrastructure and energy development.

Advanced equipment driving industrial upgrades: The highlight was Neusoft Medical’s self-developed NeuViz Epoch Elite CT scanner, the world’s fastest 16 cm spiral CT, which drew wide attention with its ultra-fast scans and crystal-clear imaging.

Innovation services enabling technology transformation: Genertec showcased how innovation services act as the engine of tech upgrades. Using VR-based virtual machine tools, visitors could “step inside” machines, see their structure clearly, and even simulate dismantling—turning complex industrial technology into something tangible.

Building collaboration platforms: Industry forum and youth dialogue

As one of CAEXPO’s official side events, the forum featured keynote speeches, signing ceremonies, and roundtable discussions, showcasing achievements in international engineering and equipment cooperation. Around 200 guests attended.

Guest speakers—including senior Chinese and ASEAN officials—praised Genertec’s achievements in advancing Belt and Road cooperation and opening new channels for collaboration. They offered insights on deepening industry chain cooperation, building modern industrial systems, and promoting regional integration.

In the Gen Z Roundtable, ASEAN youth in China and Genertec’s Chinese and foreign employees, exchanged views on regional cooperation, green transition, and cross-cultural communication.

Looking ahead

Genertec will continue focusing on ASEAN’s needs in infrastructure and advanced equipment, deepening trust and expanding cooperation with governments, enterprises, and institutions across the region.

Hashtag: #Genertec

The issuer is solely responsible for the content of this announcement.

Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811)

SHANGHAI, Sept. 24, 2025 /PRNewswire/ — Hengrui Pharma (600276.SH; 01276.HK), a leading innovative global pharmaceutical company focused on scientific and technological innovation, announced today that it has entered into an exclusive license agreement with Glenmark Specialty S.A. (GSSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd., which is a research-led, global pharmaceutical company, for Hengrui’s independently developed HER2-targeting ADC, Trastuzumab Rezetecan (SHR-A1811).

Under the terms of the agreement, Hengrui has granted Glenmark exclusive rights to develop and commercialize Trastuzumab Rezetecan worldwide, excluding Mainland China, the Hong Kong SAR, the Macao SAR, Taiwan Region, USA, Canada, Europe, Japan, Russia, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan and Uzbekistan. Glenmark will pay Hengrui an upfront payment of US$18 million. Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion. Based on the net sales of Trastuzumab Rezetecan within the licensed territory, Glenmark will pay corresponding royalties to Hengrui.

Jo Feng, President of Hengrui Pharma, said:

“Facing the major global challenge of cancer treatment, Hengrui has over the years accelerated the research and development of cutting-edge innovative therapies such as ADCs, and is committed to addressing clinical treatment challenges and meeting unmet medical needs. This collaboration with Glenmark is a significant step in Hengrui’s ongoing strategy to deepen its presence in emerging markets. We look forward to working together to enhance the accessibility of innovative therapies and to bring new hope to patients in more countries and regions.”

Glenn Saldanha, Chairman and Managing Director of Glenmark, said:

“We are delighted to collaborate with Hengrui and build on the scientific momentum of Trastuzumab Rezetecan (SHR-A1811) as we continue expanding our oncology pipeline and leadership. This partnership aligns strongly with our strategy to bring differentiated, high-value therapies to patients and reinforces our commitment to advancing innovation in areas of significant unmet need.”

Trastuzumab Rezetecan is Hengrui’s self-developed HER2-targeted ADC. In May 2025, it was approved in China for the treatment of adult patients with HER2 (ERBB2) activating mutations in unresectable locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least one prior systemic therapy. This is the first China-developed ADC approved for HER2-mutated NSCLC. In September 2025, the new indication for Trastuzumab Rezetecan in breast cancer was accepted by China’s NMPA for review and was included in the priority review program. To date, Trastuzumab Rezetecan has been included in the NMPA’s Breakthrough Therapy Designation list for nine indications, covering NSCLC, breast cancer, gastric or gastroesophageal junction adenocarcinoma, colorectal cancer, biliary tract cancer, and gynecologic malignancies.

Currently, Trastuzumab Rezetecan is actively advancing multiple clinical trials. In August 2025, Trastuzumab Rezetecan in combination with adebrelimab and chemotherapy obtained Orphan Drug Designation from the US FDA for gastric or gastroesophageal junction adenocarcinoma.

Notably, based on its proprietary modular ADC platform (HRMAP®) and over 10 years of experience in ADC research and development, Hengrui Pharma has become a leading domestic enterprise in the layout of popular targets, with a number of differentiated ADC products. At present, more than 10 differentiated ADC molecules, including Trastuzumab Rezetecan, have been successfully approved for clinical trials. As of June 2025, 6 of Hengrui’s ADC products are in Phase III clinical trials or beyond, and a number of innovative drug products are deployed in various solid tumor treatment fields.

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Ltd. (BSE: 532296 | NSE: GLENMARK) is a research‐led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. Glenmark Pharmaceuticals has 11 world-class manufacturing facilities spread across 4 continents, and operations in over 80 countries. Scrip 100 positions Glenmark Pharmaceuticals amongst the Top 100 biopharmaceutical companies ranked by Pharmaceutical Sales in 2023. For more information, please visit the following website of Glenmark Pharmaceuticals: www.glenmarkpharma.com.

About Hengrui Pharma

Hengrui Pharma is an innovative, global pharmaceutical company dedicated to the research, development and commercialization of high-quality medicines to address unmet clinical needs. Its therapeutic areas of focus include oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. Founded in 1970 with the core principle of putting patients first, Hengrui Pharma remains committed to advancing human health by striving to conquer diseases, improve health, and extend lives through the power of science and technology.

learnd SE: Sale of a majority stake in learnd Ltd. as part of a management buy-out and appointment of former chairman of the supervisory board as sole member of the management board

Public disclosure of inside information pursuant to Article 17 para. 1 of Regulation (EU) No 596/2014 on market abuse (Market Abuse Regulation)

Sale of a majority stake in learnd Ltd. as part of a management buy-out and appointment of former chairman of the supervisory board as sole member of the management board

LUXEMBOURG – EQS Newswire – 24 September 2025 – learnd SE (ISIN: LU2358378979, Stock Exchange: Frankfurt) (the “Company”) announces the sale of a majority stake in its operating subsidiary, learnd Ltd., as part of a management buy-out to a company controlled by its former management board members, as well as the appointment of the former chairman of the supervisory board as sole member of the management board.

Sale of 50.5% of shares in learnd Ltd.

Today, the Company has entered into a share purchase agreement with learnd Arrow Limited regarding the sale of 50.5% of the shares in its subsidiary, learnd Ltd. (the “Transaction”). The Transaction values learnd Ltd. at an enterprise value of EUR 48.5 million. The sale will result in the Company receiving an amount of EUR 10,455,693.00. In addition, as part of the Transaction, all outstanding intra-group loans will be settled; as a consequence, the Company will receive an additional amount of EUR 10,799,307.00. learnd Arrow Limited is indirectly controlled by John Clifford and Simon Wood, the two former members of the management board of the Company. learnd Ltd. encompasses the operating business of the Company. The share purchase agreement was entered into on customary market terms. The Transaction is subject to the clearance under the National Security and Investment Act of the United Kingdom, which is expected to be obtained prior to October 2, 2025. After the Transaction is completed, the Company will retain an indirect minority stake of 49.5% of the shares in learnd Ltd.

In parallel with the Transaction, the Company will acquire all shares in the Company held by the two former members of the management board for no consideration, except for one share each (the “Repurchase”). The Company intends to propose the cancellation of such repurchased shares to its shareholders in the next general meeting. Additionally, both former members of the management board will waive (i) their claims to certain bonus payments to which they were entitled and (ii) all of their options to subscribe for shares in the Company (the “Waiver”). Both the Repurchase and the Waiver are subject to (i) the completion of the Transaction and (ii) the approval of the cancellation of the repurchased shares by the Company’s general meeting.

In connection with the share purchase agreement, the Company has entered into a shareholders’ agreement with the new majority shareholder of the operating company. This shareholders’ agreement grants the Company, inter alia, the right to nominate one of up to four members of the board of directors of the operating company. Certain extraordinary measures related to the management of the operating company are subject to the Company’s approval.

Use of the proceeds from the sale

The Company intends to use the net proceeds from the sale as follows: (i) approximately 40% for the repayment of existing shareholder loans and another loan, and (ii) approximately 30% for the repayment of acquisition financing utilized for prior acquisitions. The remaining funds will be allocated to cover operating costs and, to the extent available, for distribution to the Company’s shareholders.

New appointment to the management board and changes in the supervisory board

Immediately prior to the Transaction, John Clifford and Simon Wood have resigned from the management board of the Company to avoid conflicts of interest. The supervisory board of the Company has appointed Gisbert Rühl, the former chairman of the supervisory board and co-founder of the SPAC GFJ ESG Acquisition I SE, as sole member of the management board of the Company. As his successor, the supervisory board appointed Johann Stachow, former general counsel of Xella International GmbH, as a member and chair of the supervisory board of the Company. The supervisory board consists of Johann Stachow (chair), Karl-Theodor zu Guttenberg, and Stefan Spang.

Important Notice

This announcement may contain forward-looking statements based on current assumptions and forecasts made by the Company’s management board. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expected in such statements. The Company assumes no obligation to publicly update or revise any such statements.

Hashtag: #learndSE

The issuer is solely responsible for the content of this announcement.

Bybit Crypto Insights Report: Aster Takes on Hyperliquid in the Perp DEX Boom

DUBAI, UAE, Sept. 24, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has released its latest Bybit Crypto Insights report, analyzing the growth of decentralized perpetual exchanges and how Aster has emerged as a competitor to Hyperliquid.

Bybit has entered the onchain DEX race with Byreal, a Solana-based decentralized exchange now in beta and set for mainnet in early October. According to DefiLlama, Byreal has recorded more than $335.41M in cumulative trading volume since its beta launch, with daily volume peaking at $28.15M. TVL reached a high of $14.22M. Byreal uses hybrid liquidity models, including RFQ and CLMM mechanisms, to reduce slippage and curb MEV.

The Rise of Aster

Aster was formed from the merger of Astherus and ApolloX and launched in September with a token that surged more than 300 percent in hours. The ASTER token reached a $1.33 billion market cap within two days. Aster’s features include MEV-free execution, hidden orders and dual trading interfaces designed for both retail and professional users. Plans for a zero-knowledge-powered chain and integration with the Binance ecosystem have strengthened its early positioning.

How Aster stacks up against Hyperliquid

Hyperliquid remains the leading decentralized perp DEX, recording about $200 billion in September trading volume compared with Aster’s $20 billion. Its market capitalization is estimated at $13.2 billion, while Aster’s is about $2.5 billion.

The two platforms reflect contrasting strategies. Hyperliquid built its own Layer 1 infrastructure with HyperBFT consensus and sub-second finality, delivering centralized exchange-like execution entirely on chain. Aster was mainly launched on BNB Chain with a modular design and emphasizes ecosystem integration, branding and token-driven growth.

How is Hyperliquid different from dYdX/GMX?

Legacy platforms such as dYdX and GMX emphasize decentralization as a core principle. By comparison, newer players like Hyperliquid and Aster prioritize speed, liquidity and user experience. Both sacrifice a degree of decentralization in favor of performance.

Hyperliquid and beyond

Bybit’s report notes that ideals such as trustlessness and community governance are taking a back seat to execution and user experience. Hyperliquid has long been the sector’s benchmark, having developed a blockchain optimized for trading, with fully on-chain matching and sub-second settlement.

Aster, however, has gained visibility not by building new infrastructure but by capturing attention through narrative, exchange backing and incentives. Its rapid rise illustrates how token launches, partnerships and endorsements can shift market dynamics.

The road ahead

The report concludes that decentralized perpetual DEXs are evolving into a model where decentralization is treated as a feature rather than a foundation. With centralized exchanges capable of launching their own versions, competition is expected to increase.

Hyperliquid, once seen as untouchable, now faces an existential challenge. Its infrastructure remains strong, but the market increasingly rewards storytelling, ecosystem incentives and cultural resonance alongside technical performance.

Read more about Aster’s emergence, Hyperliquid’s position and the evolving landscape of decentralized perpetual exchanges in the Bybit Crypto Insights Report: The rise of decentralized perp DEXs: How Aster matches Hyperliquid.

#Bybit / #TheCryptoArk /#BybitResearch

Bybit Crypto Insights Report: Aster Takes on Hyperliquid in the Perp DEX Boom
Bybit Crypto Insights Report: Aster Takes on Hyperliquid in the Perp DEX Boom

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 70 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

 

The “Menstrual Equity Project” Launched in The Bahamas to Boost School Attendance for Girls

PROVIDENCIALES, Turks and Caicos Islands, Sept. 24, 2025 /PRNewswire/ — KuCoin, a leading global crypto platform built on trust, has recently advanced the Menstrual Equity Project in 2025 in The Bahamas. Jointly launched by KuCoin, the Global CSR Foundation, and the American Medical Women’s Association (AMWA), this initiative addresses menstrual health challenges in underserved communities.

Conceptualized in 2023 by Dr. Padmini Murthy, AMWA’s Global Health Lead and NGO Representative to the United Nations, and Ms. Jing Cesarone, Founder and CEO of the Global CSR Foundation, the project focuses on providing essential support. H.E. First Lady of The Bahamas, Mrs. Ann Marie Davis, personally spearheaded the distribution, delivering menstrual hygiene products donated by these global partners to local schools and communities.

“There are girls stay home from school while menstruating, as they cannot afford to buy their napkins,” said Mrs. Davis at the distribution event. “I couldn’t believe the great need for this product here in the Bahamas in underserved communities. I’m extremely grateful to my Global Partner, for her much-needed donation of sanitary pads.”


This effort is part of KuCoin’s broader commitment to social responsibility, made during the KuCoin Green Future Reception at COP28 in 2023. Since then, KuCoin has actively carried out various welfare initiatives. One of the flagship programs, the Menstrual Equity Project, launched its first distribution in March 2024, providing menstrual kits—including sanitary pads and menstrual cups—to beneficiaries in the Republic of Suriname, St. Jude Children’s Research Hospital, and domestic violence shelters in New York.

Following these initial efforts, the project extended its reach to The Bahamas.

With support from the Office of The Spouse of The Prime Minister, KuCoin’s donations to The Bahamas mainly include disposable sanitary pads. KuCoin’s approach also considers local limitations in water resources and the high cost of cleaning reusable products. It also ensures women are better equipped during natural disasters such as hurricanes and tropical storms.


The objectives of KuCoin’s Menstrual Equity Project align closely with those of the Distribution of Feminine Pads Initiative led by the First Lady’s Office. Together, they aim to reduce absenteeism among schoolgirls caused by period poverty, while also fostering greater awareness and acceptance of menstrual health issues within the community.

“Your donation has made a tangible impact on the lives of those we support. The pads were distributed to Parliamentarians for inner city areas, NGOs, the girls penitentiary centre for girls, and many caretakers of young girls and battered women. The recipients were overjoyed and expressed the great need for these supplies, which are expensive. The distribution was great. These pads were significant in enabling the recipients to manage their menstrual health with confidence and dignity.” Mrs. Ann Marie Davis, Spouse of The Prime Minister of The Bahamas, wrote a personal letter of thanks, “We are deeply thankful for your compassion and commitment to improving the lives of others. Thank you for your kindness and generosity. We look forward to continuing our work together to empower and support our communities.”

KuCoin’s efforts in corporate social responsibility have been widely recognized in recent years. In March 2025, KuCoin was honored with the “2025 Corporate Social Responsibility Award” from the World Women Organization.

“The Menstrual Equity Project is not only about health and dignity—it’s about equity,” said Nancy Cheung, Chief Sustainability Officer at KuCoin. “We are committed to expanding this project globally, collaborating with more organizations to improve the living conditions of women and contribute to the well-being of women and children around the world.”

As KuCoin embarks on a new chapter of global compliance and sustained growth in 2025, initiatives like the Menstrual Equity Project are becoming vital pillars of its long-term sustainability strategy—fortifying the platform’s social value moat and setting a new benchmark for responsible innovation in the crypto industry.

About KuCoin

Founded in 2017, KuCoin is a leading global crypto platform built on trust, serving over 41 million users across 200+ countries and regions. With established recognition for its reliability, the platform leverages cutting-edge blockchain technology, robust liquidity solutions, and advanced user account protections to deliver a secure trading environment. KuCoin offers access to 1,000+ digital assets and solutions including Web3 wallet, Spot and Futures trading, institutional services, and payments. Recognized by Forbes as one of the “Best Crypto Apps & Exchanges” and a “Top 50 Global Unicorn” by Hurun, KuCoin holds SOC 2 Type II and ISO 27001:2022 certifications and is committed to security, compliance, and innovation under the leadership of CEO BC Wong.

Learn more: https://www.kucoin.com/

 

xLean TR1 Wraps Up IFA 2025 With Major Innovation Wins

BERLIN, Sept. 24, 2025 /PRNewswire/ — xLean Robotics concluded a standout IFA 2025 showcase (Sept. 5–9) in Berlin, where the xLean TR1 billed as the world’s first dual-form transformable floor washing robot captured multiple honors, including Best in IFA Next Winner and Best in Design Honoree, and was named among Tom’s Guide’s “Top 5 Cleaning Robots”. Homecrux also highlighted TR1 as one of the fair’s most notable smart-home innovations.

xLean TR1 Wraps Up IFA 2025 With Major Innovation Wins
xLean TR1 Wraps Up IFA 2025 With Major Innovation Wins

Live demos showcased TR1’s one-second transition from autonomous robot to handheld drew sustained interest from dealers, trade press, and consumers. Visitors praised the design as intuitive and genuinely practical for real-world messes from large spills and liquid-solid mixtures to quick spot cleaning in kitchens and living areas. The detachable, bi-directional powered handle delivers a lightweight handheld experience and reduces user fatigue during spot cleaning work.

Engineered for everyday use, TR1 combines advanced perception with an all-new cleaning mechanism. Multi-sensor fusion and Reinforcement Learning algorithm steer its compact square chassis through tight spaces, while 800-RPM dual rollers and the Dual-Motor DirectSuction™ cleaning system clear solids and liquids in a single pass. xLean’s VortexMatrix™ separation technology achieves separation of water and high-speed airflow, prevents clogs without bulky hardware. The Smart OMNI Station automates liquid-solid waste separation, runs a 60°C hot-water flush, and air-dries components to minimize maintenance.

Beyond hardware, xLean TR1 is also built with Reinforcement Learning with human feedback (RLHF) enables the robot to learn household patterns and optimize cleaning behavior while keeping user privacy as a core design principle. That combination of hardware reliability and adaptive intelligence positioned TR1 as an outstanding floor robot cleaners at the IFA show.

“Seeing so many attendees test the xLean TR1 and praise its dual-form flexibility and effortless handheld use was incredibly encouraging”, said Kehan Xue, Founder & CEO of xLean Robotics. “The awards and booth response reinforce our mission to build privacy-first, continuously evolving robots that tackle the messy realities of daily life.”

xLean also received a “Best of Kickstarter” badge at IFA. TR1 is now available for pre-launch on Kickstarter where interested users can click Follow ahead of its full campaign expected in late October: https://www.kickstarter.com/projects/xlean/xlean-tr1-dual-form-transformable-floor-washing-robot 

Retail availability and preorder information will be posted at: www.xlean.ai

Media contact: David Kwok, davy@xlean.ai

Young Luang Prabang Artisan Wins Global Award for Lao Embroidery

The handicraft work by Khounphithack Latesavat.

Lao handicrafts shone brightly on the global stage, as a unique embroidery technique by a young Lao artisan won the Youngest Artisan award at this year’s International Festival of Handicrafts in Kokand, Uzbekistan.